Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05204082 · ClinicalTrials.gov registry record · NA
A Study to Evaluate SU-VEID™ for Improving Peripheral Venous Access Success in Children
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 169
- Enrollment target
NCT05204082: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT05204082 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 169 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05204082, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 169 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if use of the SU-VEID™ in children facilitates an increase success rate of peripheral intravenous starts, in comparison to the conventional method of vein entry techniques.
Interventions
- DEVICE Single Use Vein Entry Indicator Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 169 participants |
| Start Date | 2022-03-28 |
| Est. Completion | 2022-07-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05204082
The ClinicalTrials.gov registry entry for NCT05204082 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 169 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Single Use Vein Entry Indicator Device is the first listed.
NCT05204082 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05204082 about?
NCT05204082 is a clinical study titled "A Study to Evaluate SU-VEID™ for Improving Peripheral Venous Access Success in Children". The purpose of this study is to determine if use of the SU-VEID™ in children facilitates an increase success rate of peripheral intravenous starts, in comparison to the conventional method of vein entry techniques.
What is the current status of trial NCT05204082?
This trial is currently terminated. It is a NA study. The enrollment target is 169 participants. The study started on 2022-03-28. Estimated completion is 2022-07-21.
What interventions are being tested in trial NCT05204082?
The interventions under investigation include: Single Use Vein Entry Indicator Device (DEVICE).
Who is sponsoring clinical trial NCT05204082?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.